Ultragenyx Pharmaceutical Inc.
RARE
$35.11
-$0.87-2.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 19.99% | 5.69% | 37.42% | 38.38% | -34.52% |
| Total Receivables | 2.38% | 65.93% | 19.38% | 48.69% | 80.38% |
| Inventory | 28.20% | 32.49% | 36.26% | 42.05% | 34.91% |
| Prepaid Expenses | -- | -28.81% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -82.16% | 238.94% | 2,615.84% | 2,989.62% | 2,319.91% |
| Total Current Assets | 17.31% | 11.60% | 33.45% | 37.39% | -22.23% |
|
|
|||||
| Total Current Assets | 17.31% | 11.60% | 33.45% | 37.39% | -22.23% |
| Net Property, Plant & Equipment | -8.49% | -7.33% | -15.71% | -9.57% | -5.22% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 6.96% | 7.24% | 4.86% | 5.06% | 3.69% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.01% | 10.05% | 93.12% | 103.00% | 169.42% |
| Total Assets | 0.37% | 0.83% | 24.25% | 23.42% | -5.52% |
|
|
|||||
| Total Accounts Payable | 15.81% | -7.97% | 7.89% | 42.01% | -30.53% |
| Total Accrued Expenses | 16.01% | 22.64% | 3.59% | -7.89% | 3.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 22.34% | 43.76% | 40.85% | 69.43% | 274.95% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 18.77% | 22.72% | 12.22% | 11.66% | 12.56% |
|
|
|||||
| Total Current Liabilities | 18.77% | 22.72% | 12.22% | 11.66% | 12.56% |
| Long-Term Debt | -6.44% | -4.93% | -5.29% | -4.41% | -4.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.69% | -1.74% | -31.54% | 73.40% | 61.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.94% | 11.54% | 10.23% | 7.60% | 8.83% |
| Total Liabilities | -0.53% | 2.10% | -1.81% | 0.32% | 0.33% |
|
|
|||||
| Common Stock & APIC | 14.96% | 15.03% | 26.41% | 27.39% | 16.71% |
| Retained Earnings | -15.44% | -16.80% | -17.12% | -18.85% | -20.83% |
| Treasury Stock & Other | 20.88% | -199.38% | 139.93% | 64.65% | 89.14% |
| Total Common Equity | 2.84% | -7.30% | 993.61% | 235.13% | -36.38% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.84% | -7.30% | 993.61% | 235.13% | -36.38% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.83% | -4.76% | 1,015.68% | 235.13% | -36.38% |
|
|
|||||